Gilead Sciences

Biotechnology

Gilead Sciences is a biopharmaceutical company that pioneered treatments for HIV/AIDS and hepatitis C, transforming these diseases from death sentences to manageable conditions. The company continues to focus on virology, oncology, and inflammation. Gilead's antiviral expertise made it a key player in COVID-19 treatment development.